Clinical Trial Results: Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rilzabrutinib for chronic spontaneous urticaria in patients who remain symptomatic despite H1 antihistamines; results complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• Rilzabrutinib (rilzabrutinib)

Snippet

Sponsor: Sanofi | Conditions: Chronic Spontaneous Urticaria | Phase 2 | Status: COMPLETED | Results posted: 2026-08-06